Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab Pharmacodynamics and Efficacy in Renal Transplant
NCT01596062Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of basiliximab in kidney transplant rejection, sponsored by Novartis. Started Mar 2012; status: completed.
02
Drugs
basiliximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01596062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01596062.